News & Updates

Challenges and strategies in the management of MDRO infections in Asia

20 Dec 2021 by

Multidrug-resistant organisms (MDROs) are associated with a longer hospital stay, increased exposure to antimicrobial agents, and excess healthcare costs. Improved treatment and management strategies are urgently needed to curb the rising burden of MDROs in Asia. At a symposium organized by Pfizer in conjunction with the 18th Asia Pacific Congress of Clinical Microbiology and Infection (APCCMI 2021), experts discussed the role of rapid diagnostic testing and novel antibiotics in addressing MDRO infections, including practical solutions to maximize patient outcomes while minimizing the risk of antimicrobial resistance. The esteemed speakers were Professor Tobias Welte, Head, Department of Respiratory Medicine and Infectious Diseases, Hannover Medical School, Germany, and Dr Asok Kurup, Infectious Diseases Consultant at Mount Elizabeth Medical Centre, Singapore. Professor Balaji Veeraraghavan, Head of the Department of Clinical Microbiology, Christian Medical College and Hospital, Vellore, India, chaired the session.

Challenges and strategies in the management of MDRO infections in Asia

20 Dec 2021

Kids hard-hit by Delta; which ART performs best?

24 Oct 2021 by

That COVID-19 mostly spared children might be changing. The Delta variant has taken a severe, unthinkable toll on kids – at least in Arkansas, US, reports an expert at IDWeek 2021.

Kids hard-hit by Delta; which ART performs best?

24 Oct 2021

Rapid antigen test: Don’t let perfect be the enemy of good

23 Oct 2021 by

While rapid antigen test is less sensitive than conventional nucleic acid amplification test (NAAT) such as RT-PCR* in detecting SARS-CoV-2 virus, “a test does not have to be perfect to be clinically useful,” said Professor Angela Caliendo during a session in IDWeek 2021 — echoing the maxim that perfect should not be the enemy of good in the pandemic era.

Rapid antigen test: Don’t let perfect be the enemy of good

23 Oct 2021

Rapid COVID-19 testing: Is it as good in kids?

20 Oct 2021 by

A large retrospective study from the US, presented at IDWeek 2021, has shown that the Abbott ID NOW rapid molecular COVID-19 assay is highly sensitive and specific at detecting SARS-CoV-2 infection in a paediatric population.

Rapid COVID-19 testing: Is it as good in kids?

20 Oct 2021

Current management of nosocomial and community-acquired pneumonia in ICU patients with novel antibiotics

27 Aug 2021 by

Nosocomial pneumonia serves as a paradigm for all severe infections, and appropriate antibiotic therapy is the key determinant of patient outcomes. Most data for the use of antibiotics are derived from studies in non-ICU patients and ignore critical care issues such as fluid resuscitation, mechanical ventilation, and changing renal function. Against the backdrop of increasing antimicrobial resistance and the COVID-19 pandemic, how do we optimize antibiotic administration in the ICU? Professor Andrew Shorr from Washington Hospital Center, Georgetown University, Washington DC, US discussed this burning issue at a Pfizer-sponsored satellite symposium, held during the Asia Pacific Intensive Care Symposium (APICS) 2021.

Current management of nosocomial and community-acquired pneumonia in ICU patients with novel antibiotics

27 Aug 2021

Antigen rapid tests: The new COVID-19 strategy moving forward?

31 Jul 2021 by

Same-day pre-event screening for SARS-CoV-2 using antigen-detecting rapid diagnostic tests (Ag-RDT) may enable the resumption of large-scale indoor events which were halted or had their attendance capacity reduced during the COVID-19 pandemic, according to a study from Spain presented at ECCMID 2021.

Antigen rapid tests: The new COVID-19 strategy moving forward?

31 Jul 2021

Combined Ag/Ab rapid testing boosts case-finding in COVID-19

29 Jul 2021 by

A rapid and affordable test for diagnosing COVID-19 outside the walls of the healthcare units could improve case-finding, contact tracing, and infection control, says an expert during a pre-ECCMID 2021 session.

Combined Ag/Ab rapid testing boosts case-finding in COVID-19

29 Jul 2021

Antigen rapid test vs RT-PCR for COVID-19: What you need to know

29 Jul 2021 by

While RT-PCR is the current gold standard to confirm a SARS-CoV-2 infection, antigen rapid test (ART) for COVID-19 allows for quick detection of SARS-CoV-2 and thus fast triaging of infected patients requiring isolation at the population level, according to studies presented at ECCMID 2021.

Antigen rapid test vs RT-PCR for COVID-19: What you need to know

29 Jul 2021

Antigen rapid tests: Moving toward more efficient COVID-19 testing

01 Jul 2021 by

At the time of writing, there have been 175,306,598 confirmed infections and 3,792,777 deaths attributed to the COVID-19 pandemic globally. [https://covid19.who.int/, accessed 14 June 2021] Real-time reverse transcription polymerase chain reaction (RT-PCR) has been instrumental in detecting the infection and preventing more widespread transmission of the disease.

Antigen rapid tests: Moving toward more efficient COVID-19 testing

01 Jul 2021

Management of MDROs in the ICU and the role of newer antimicrobial agents

30 Mar 2021 by

Intensive care unit (ICU) patients are at risk of developing serious infections with multidrug-resistant organisms (MDROs), which require appropriate and adequate antibiotic coverage. Early empirical coverage is pivotal in saving patients’ lives. At a recent webinar co-organized by the Society of Infectious Disease (Singapore) and Pfizer, renowned Professor David Paterson, Professor of Medicine and Director, The University of Queensland Centre for Clinical Research, and Consultant Infectious Diseases Physician, Royal Brisbane and Women’s Hospital, Brisbane, Australia, discussed the role of newer antimicrobial agents, including ceftazidime-avibactam (Zavicefta) in the management of MDROs in the ICU. Dr Wong Sin Yew, Infectious Disease Physician at Gleneagles Medical Centre and Mount Elizabeth Novena Specialist Centre, Singapore, chaired the event.

Management of MDROs in the ICU and the role of newer antimicrobial agents

30 Mar 2021

News & Updates

Filter by Specialty:

Specialty:

Challenges and strategies in the management of MDRO infections in Asia

Challenges and strategies in the management of MDRO infections in Asia

Kids hard-hit by Delta; which ART performs best?

Kids hard-hit by Delta; which ART performs best?

Rapid antigen test: Don’t let perfect be the enemy of good

Rapid antigen test: Don’t let perfect be the enemy of good

Rapid COVID-19 testing: Is it as good in kids?

Rapid COVID-19 testing: Is it as good in kids?

Current management of nosocomial and community-acquired pneumonia in ICU patients with novel antibiotics

Current management of nosocomial and community-acquired pneumonia in ICU patients with novel antibiotics

Antigen rapid tests: The new COVID-19 strategy moving forward?

Antigen rapid tests: The new COVID-19 strategy moving forward?

Combined Ag/Ab rapid testing boosts case-finding in COVID-19

Combined Ag/Ab rapid testing boosts case-finding in COVID-19

Antigen rapid test vs RT-PCR for COVID-19: What you need to know

Antigen rapid test vs RT-PCR for COVID-19: What you need to know

Antigen rapid tests: Moving toward more efficient COVID-19 testing

Antigen rapid tests: Moving toward more efficient COVID-19 testing

Management of MDROs in the ICU and the role of newer antimicrobial agents

Management of MDROs in the ICU and the role of newer antimicrobial agents